OverviewChartNewsTraderScreen

BVT Knock-Out Bayer AG/  DE000VU3EP94  /

Frankfurt Zert./VONT
2024-04-10  10:14:04 AM Chg.-0.040 Bid11:49:04 AM Ask11:49:04 AM Underlying Strike price Expiration date Option type
4.990EUR -0.80% -
Bid Size: -		 -
Ask Size: -		 BAYER AG NA O.N. 77.70 - 2078-12-31 Put
GlobeNewswire 2:00 PM AskBio Announces Nine Presentations at American Society of Gene and Cell Therapy 27th Annual Meeting...
GlobeNewswire 2:00 PM Daré Bioscience Selected as a Member of ARPA-H Investor Catalyst Hub Spoke Network
GlobeNewswire 2:00 PM Data and AI Consultancy Indicium Scales with $40 Million Investment from Columbia Capital
GlobeNewswire 1:30 PM BridgeBio Pharma Reports First Quarter 2024 Financial Results and Business Update
GlobeNewswire 1:00 PM CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results ...
GlobeNewswire 12:30 PM Regeneron Reports First Quarter 2024 Financial and Operating Results
TeleTrader 9:02 AM Europe opens mixed amid data, earnings
GlobeNewswire 05-01 EY Announces Guru Hariharan of CommerceIQ as an Entrepreneur Of The Year® 2024 Bay Area Award Finali...
GlobeNewswire 04-18 AskBio receives FDA Fast Track Designation for AB-1002 investigational gene therapy program in conge...
GlobeNewswire 04-16 AskBio presents 18-month Phase Ib trial results of AB-1005 gene therapy for patients with Parkinson’...
GlobeNewswire 04-11 Daré Bioscience Announces Publication in Contraception of Positive Efficacy and Safety Findings from...
GlobeNewswire 04-09 AskBio Names Mansuo Shannon Chief Scientific Officer
GlobeNewswire 03-25 BlueRock Therapeutics and Foundation Fighting Blindness announce collaboration to expand the Uni-Rar...
GlobeNewswire 03-14 Bayer and Aignostics to collaborate on next generation precision oncology
GlobeNewswire 03-06 BlueRock Therapeutics phase I clinical trial for Parkinson’s disease continues to show positive tren...
TeleTrader 03-05 Bayer's Q4 sales at €11.9 billion
GlobeNewswire 03-04 BridgeBio Pharma and Bayer Announce European Licensing Agreement for Acoramidis in ATTR-CM
TeleTrader 03-04 Earnings preview: Bayer, Broadcom among those in calendar
GlobeNewswire 02-15 2Blades Delivers on Project with Bayer Crop Science to Combat Asian Soybean Rust
GlobeNewswire 02-13 Corporate Alignment with Climate Goals Under Scrutiny: LyondellBasell & Bayer demonstrate good pract...
GlobeNewswire 02-13 First patient randomized in AskBio Phase II gene therapy trial for congestive heart failure
TeleTrader 01-29 Bayer down over 5% after latest $2.25B Roundup ruling
TeleTrader 01-17 Bayer to cut jobs amid 'difficult situation'
GlobeNewswire 01-05 AskBio Announces Initiation of Phase 2 GenePHIT Trial in Congestive Heart Failure (CHF)
GlobeNewswire 01-04 AskBio Phase Ib trial of AB-1005 gene therapy in patients with Parkinson’s disease meets primary end...